ABI-4334

N/A

Report date: 2024/12/09 13:28:11
NME

Base Information

Drug NameABI-4334
Drug Alias NameABI4334ABI-43344334
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionViral core proteins inhibitors
TargetsViral core proteins
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandMoldova, Republic of
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAssembly Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAssembly Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A